InnoGI Technologies and Bac3Gel Forge Partnership to Revolutionize Gut Microbiome Research
Gut3Beads, a next generation for in vitro colonic research developed by Bac3Gel, are innovative hydrogel beads that replicate the colonic microenvironment, providing a mucin-like substrate to cultivate diverse intestinal microbiota. This cutting-edge technology enables researchers to better mimic the native gut environment, addressing key challenges in gut microbiome research.
Gut3Beads, a next generation for in vitro colonic research developed by Bac3Gel, are innovative hydrogel beads that replicate the colonic microenvironment, providing a mucin-like substrate to cultivate diverse intestinal microbiota. This cutting-edge technology enables researchers to better mimic the native gut environment, addressing key challenges in gut microbiome research.
By combining InnoGI's expertise in dynamic gut modeling with Bac3Gel's advanced technology, the partnership will integrate Gut3Beads into InnoGI's proprietary SurroGUT™ platform based on TIM technology, creating a synergistic solution for gastrointestinal research and drug development.
"Partnering with Bac3Gel is a significant milestone for InnoGI Technologies, reflecting our commitment to advancing gastrointestinal research by incorporating innovative tools that complement the predictive capabilities of our SurroGUT™ platform," says Behzad Mahdavi, PhD, MBA CEO of InnoGI Technologies. "Together, we are redefining standards for simulating the complete human gut microbiome, empowering our customers to achieve groundbreaking discoveries in drug development and beyond.".
"Gut3Beads are designed to replicate the key physical and chemical properties of colonic intestinal mucus, enabling microbiota to thrive as they would in their native environment," explains Sebastião van Uden, CEO of Bac3Gel. "This partnership amplifies our ability to deliver unparalleled solutions for microbiome research."
A New Standard in Gut Microbiome Research
Gut3Beads introduce a revolutionary approach to microbiome research, allowing the study of complex microbial communities, drug–mucus interactions, and their impact on the colonic microbiome. Compatibility with SurroGUT™ and TIM technology offers researchers a state-of-the-art tool to stimulate the colonic environment and accelerate scientific discovery.
